Delivery Order SPE2DB22D1103-SPE2DB25FTJP9
Award Date
4/3/25
Potential Completion Date
4/4/25
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,302.11, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. This award is not designated under any set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,388.52, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. This is a delivery order contract with a firm fixed price pricing type and a completion date of February 7, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a $4,418.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medical product, with a period of performance through November 3, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,557.06, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. It is a firm fixed-price delivery order contract with an ultimate completion date of April 8, 2025. This award is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,271.31, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 19, 2024. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,407.23, is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of December 18, 2024. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medical product. The contract has a ceiling value of $4,658.93 and a completion date of July 24, 2024. It is a firm fixed price contract without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,832.90, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of April 3, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $2,047.50 contract provides WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication, to support DLA's medical supply programs. The contract has a completion date of January 29, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,629.90, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...